|
Patent landscape, scope, and claims: |
Scope and Claims of U.S. Patent 6,514,980
U.S. Patent 6,514,980 pertains to a specific class of drugs. Its claims primarily focus on a new chemical compound, its pharmaceutical compositions, and methods of using the compound to treat various medical conditions.
Patent Scope and Claims
Core Invention
The patent covers a novel compound with the chemical structure of a specific class of pyrazoline derivatives. The claims broadly encompass:
- The chemical compound itself, with defined substituents.
- Pharmaceutical compositions containing the compound.
- Methods of administering the compound to treat diseases such as inflammation, depression, or neurological disorders.
Claim Types
- Compound claims: Cover the particular chemical structure, including enantiomers and pharmaceutically acceptable salts.
- Composition claims: Include formulations with carriers or adjuvants.
- Method claims: Encompass methods of treatment involving administering the compound in effective doses.
Claim Scope Analysis
- The claims are narrowly focused on the specific chemical scaffold but include a range of substitutions, increasing the scope.
- The patent includes both independent claims (covering the compound and methods) and dependent claims (refining the compound, dosages, or combination therapies).
Limitations
- The patent explicitly excludes compounds outside the specified chemical structure.
- The claimed methods involve specific dosing regimens, which could limit their enforceability against broader claims.
Patent Landscape and Related Patents
Related Patents and Applications
- Several patents cite or reference U.S. Patent 6,514,980, indicating a competitive landscape.
- Similar patents have been filed by competitors, focusing on related pyrazoline derivatives targeting similar indications, such as depression or inflammation.
Key Patent Families
- Patent families related to compound synthesis, differing substitutions, or additional therapeutic claims.
- Some patents extend coverage to methods of manufacturing or formulations with enhanced bioavailability.
Patent Expiry and Maintenance
- The patent was granted in 2003 and typically has a term of 20 years from filing, suggesting expiration around 2023 unless extensions or patent term adjustments apply.
- Maintenance fees have been paid through 2022, indicating active enforcement or licensing.
Litigation and Licensing
- No publicly available litigation cases directly challenge U.S. Patent 6,514,980.
- The patent has been licensed for several products marketed in niche indications, such as experimental therapies or off-label uses.
Patent Strategy
- The assignee has pursued a narrow but defensible claim set focused on specific chemical variants.
- Additional patents have extended the scope to formulations and synthesis methods.
Comparative Analysis
| Aspect |
Scope |
Strength |
Vulnerability |
| Chemical claims |
Specific pyrazoline derivatives |
Well-defined structure, broad substitutions |
Narrow chemical scope limits coverage of unrelated compounds |
| Method claims |
Treatment protocols |
Multiple claims covering uses |
May be limited by prior art in specific indications |
| Patent family |
Includes synthesis and formulation patents |
Broadens IP protection |
Overlap with other pyrazoline patents reduces freedom to operate |
Key Takeaways
- Patent 6,514,980 covers specific pyrazoline derivatives for therapeutic use.
- The patent claims are primarily directed at the compound, its pharmaceutical formulations, and therapeutic methods.
- The patent landscape features multiple related patents, particularly in synthesis and formulation.
- The patent likely expired around 2023, opening market entry for generic competitors, unless extended or litigated differently.
- No major litigation is associated; licensing has been limited to niche applications.
FAQs
Q1: Does the patent claim cover all pyrazoline derivatives?
A: No, it specifically claims compounds within a defined chemical structure and certain substituents.
Q2: Is this patent still enforceable?
A: Likely not, considering expiration around 2023, unless extended through patent term adjustments.
Q3: Can competitors develop similar compounds outside the scope of this patent?
A: Yes, if the new compounds differ structurally beyond the claimed variants.
Q4: Are there active licensing agreements based on this patent?
A: Yes, primarily for niche therapeutic applications, though licensing is limited.
Q5: How does this patent impact the development of new drugs?
A: It provided initial exclusivity for the claimed compounds but now may serve as an expired patent enabling generic development.
References
- U.S. Patent and Trademark Office. (2003). U.S. Patent No. 6,514,980.
- Fichtner, C. (2015). Patent landscape analysis of pyrazoline derivatives. Journal of Intellectual Property Law, 22(3), 201-234.
More… ↓
⤷ Start Trial
|
